Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

ONCO Stock Forecast - Oncopeptides AB

Wall St Price Targets Wall Street analysts forecast ONCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ONCO is 2.516 SEK with a low forecast of 2.02 SEK and a high forecast of 3.255 SEK . 21

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Wall St Price Targets

Wall Street analysts forecast ONCO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONCO is 2.516 SEK with a low forecast of 2.02 SEK and a high forecast of 3.255 SEK.

21% Upside

50% Upside

94% Upside

Central Garden & Pet Co

13% Upside

First Internet Bancorp

7% Upside

Schrodinger Inc

-2% Downside

Bit Digital Inc

231% Upside

Revenue
Forecast

N/A

Past Growth

73% / Year

Estimated Growth

Estimates Accuracy

-26%

Average Miss

N/A

Past Growth

73% / Year

Estimated Growth

Estimates Accuracy

-26%

Average Miss

The compound annual growth rate for Revenue over the next 3 years is 73%.

Gross Profit
Forecast

N/A

Past Growth

102% / Year

Estimated Growth

Estimates Accuracy

-14%

Average Miss

N/A

Past Growth

102% / Year

Estimated Growth

Estimates Accuracy

-14%

Average Miss

The compound annual growth rate for Gross Profit over the next 2 years is 102%.

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

1%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

1%

Average Beat

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

5%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

5%

Average Beat

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

5%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

5%

Average Beat

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

According to Wall Street analysts, the average 1-year price target for ONCO is 2.516 SEK with a low forecast of 2.02 SEK and a high forecast of 3.255 SEK.

The compound annual growth rate for Revenue over the next 3 years is 73%.

The compound annual growth rate for Gross Profit over the next 2 years is 102%.

Back to Top

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →